24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Restasis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:53
Google, Amazon and Intel stumble as investors begin to question the price of the AI boom
12:53
Every student deserves a personal tutor, inside the classroom, too.
09:51
AI companies say their models are the best. Here's how to tell if that's true
08:35
What if the AI runs out of electricity?
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Intel shares plunge as Israel factory blast compounds weak outlook
3
Cyber startup Cyera eyes $20 billion valuation in new funding talks
4
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
5
Nikesh Arora's pay falls 19.5% to $80 million as Palo Alto Networks board lowers cap on stock awards
More news
Restasis
1 stories about Restasis
Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents
23.07.18
|
CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
